Personalized Pathology & Cancer Therapy
81 – 82 of 82
                - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
        Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2010
- 
                        Mark
        Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
    
    - Contribution to journal › Article
 
- 2009
- 
                        Mark
        Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
    (2009) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 22. p.1564-1574- Contribution to journal › Article
 
